Oxygen supplementation in ambulatory patients with heart failure: a randomized proof-of-concept study
Maxime Tremblay‐Gravel(Montreal Heart Institute), Jean‐Claude Tardif(Montreal Heart Institute), Stanislav Glezer(Health Outcomes Solutions (United States)), Anna Nozza, Anique Ducharme(Montreal Heart Institute), Eileen O’Meara(Montreal Heart Institute), Normand Racine(St. Michael's Hospital), Geneviève Giraldeau(Montreal Heart Institute), Marie-Claude Parent(Montreal Heart Institute), Jacinthe Boulet(Montreal Heart Institute), Isabelle Cloutier(Montreal Heart Institute), Jean L. Rouleau(Montreal Heart Institute), Anil Nigam(Montreal Heart Institute)
Cited by 2
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
|New England Journal of Medicine|2015|2.3k
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
|New England Journal of Medicine|2012|2k